ADORA2A and metabolic dysfunction-associated steatohepatitis: Imarisio et al. reported that A2AR stimulation could prevent hepatocyte lipotoxicity and non-alcoholic steatohepatitis-associated liver inflammation and fibrosis in rats (Imarisio et al., 2012).